Navigation Links
Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
Date:12/9/2009

SAN DIEGO, Dec. 9 /PRNewswire/ -- Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery, today announced the initiation of a dose-finding study designed to evaluate the safety and efficacy of MP4OX treatment plus standard of care in severely injured trauma patients with lactic acidosis due to hemorrhagic shock. MP4OX is a novel oxygen therapeutic agent that is designed to provide rapid oxygen delivery to ischemic tissues.

"Pre-clinical studies suggest that MP4OX has the potential to improve outcomes after major trauma. When a lot of blood has been lost and patients are in shock, MP4OX may increase the delivery of oxygen to the body and therefore prevent organs from failing," said Karim Brohi, Professor of Trauma Sciences at Barts and the London School of Medicine & Dentistry and lead study investigator. "The initiation of this clinical trial is an important step in finding a treatment that can improve patient outcomes after major trauma."

The clinical trial will be a multi-center, randomized, double-blind, controlled study that will enroll up to 75 patients who have suffered hemorrhagic shock with lactic acidosis across approximately 12 trial sites in Europe and South Africa. The primary objective of the study is to measure reduction in lactate levels after infusion of MP4OX. Acute traumatic injury, including both blunt and penetrating trauma is often associated with severe bleeding which can lead to hemorrhagic shock. During shock, inadequate perfusion of critical organs can lead to insufficient oxygenation of tissues, which can be detected by an increase in lactate levels.

"The initiation of this study is another key milestone for Sangart as we continue to develop medicines designed to enhance the delivery of oxygen to tissues and organ
'/>"/>

SOURCE Sangart, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
2. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
3. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
4. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
7. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Prolexys Pharmaceuticals Initiates Phase 1 Study
11. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Calif., July 29, 2015  STAAR Surgical Company (NASDAQ: ... lenses and delivery systems for the eye today reported financial ... Second Quarter Overview , Net Sales of ... , Unfavorable Currency Impact of $2.1 Million from the Weakening ... EMEA and 13% in China , APAC Sales Down ...
(Date:7/29/2015)... DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... June 30, 2015. For the second quarter of 2015, the Company ... share, compared to a net loss of $13.4 million, or $0.18 ... six months ended June 30, 2015, the Company reported a net ... to net loss of $25.2 million, or $0.35 loss per share, ...
(Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
Breaking Medicine Technology:STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5
... MicroAire Surgical Instruments announces the ... tunnel syndrome.  MicroAire,s new device, called the SlimLine™, ... allows surgeons to treat carpal tunnel syndrome through ... thereby avoiding full open-hand surgery through the patient,s ...
... Clinical Documentation Industry Association, CDIA , today announced ... to ensuring the accuracy, consistency and security of clinical ... Medical Transcription Industry Association, MTIA , the new ... editing, voice, and speech recognition to encompass every touch ...
Cached Medicine Technology:MicroAire Introduces New SlimLine™ ECTR Cannula 2CDIA - New Trade Group for Clinical Documentation Solution Providers Set to Launch at HIMSS11 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... amount of research grants in its history of funding brain aneurysm research. ... have dedicated their life’s work toward scientific research directed at early detection, improved ...
(Date:7/30/2015)... ... ... PeopleKeys, a company with over 30 years of experience in behavioral analysis, ... the newest installment in their popular DISC for the Real World series, will air ... webinar is intended for people interested in training others to use DISC behavioral analysis ...
(Date:7/29/2015)... ... ... Drs. Hamstead are very excited to announce the expansion of AlignLife ... the clinic; massage therapy works very well alongside chiropractic care to restore balance to ... of Simpsonville to work alongside the doctors. Many people can benefit from massage therapy ...
(Date:7/29/2015)... ... 2015 , ... According to an article published July 23 by the Daily Mail, ... what a person needs to do in terms of physical activity and caloric intake to ... estimates as to the number of calories a person needs to consume to maintain or ...
(Date:7/29/2015)... ... July 29, 2015 , ... Conventional theories used by ... goods and services may be able to unlock mysteries about the behavior of microbial ... , Boston University, and Columbia University. , The findings, published July 29 in the ...
Breaking Medicine News(10 mins):Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 2Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 3Health News:Brain Aneurysm Foundation to Award Largest Amount of Research Funding 4Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:AlignLife of Simpsonville Hires Massage Therapist 2Health News:New NIH Body Weight Planner Illustrates the Need for Reduced Caloric Intake When Trying to Lose Weight, Says Beverly Hills Physicians 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3
... and Leigh NHS Foundation Trust (WWL), a major acute facility serving ... north west of England, was recently awarded NHS Foundation Trust status. ... ... -- Orion Health http://www.orionhealth.com , a leading provider of clinical ...
... Megan,s Purple Day USA by turning DrGreene.com purple for the day and ... ... and author Dr. Alan Greene is known for wearing green socks 365 ... of purple., , , , ,March 26 is Purple Day USA ...
... WASHINGTON, March 24 Surgical groups, led by the ... health care stakeholders, today announced the formation of Operation ... to bring into focus the urgent issues facing access ... With nearly 400 surgeons from around the country meeting ...
... March 24 Meningitis Angels, a Texas-based, ... is excited to support the first annual ... 2009. The observance is being coordinated and ... (CoMO), an Australia-based global advocacy group comprised ...
... and analyses from a long-running study of cancer survival in ... of cancer rather than just surviving for at least ... special issue of the European Journal of Cancer ... the first time, an estimate of the proportions of patients ...
... 23 Did you know one in six men ... to this report from Men,s Health Network at: ... over 186,000 men will be diagnosed with prostate cancer ... important to realize that prostate cancer does not affect ...
Cached Medicine News:Health News:Orion Health Congratulates Wrightington, Wigan and Leigh NHS Foundation Trust on Achieving Community-based Governance 2Health News:Orion Health Congratulates Wrightington, Wigan and Leigh NHS Foundation Trust on Achieving Community-based Governance 3Health News:Orion Health Congratulates Wrightington, Wigan and Leigh NHS Foundation Trust on Achieving Community-based Governance 4Health News:Renowned Pediatrician Joins Fight for Epilepsy Awareness for Purple Day 2Health News:Renowned Pediatrician Joins Fight for Epilepsy Awareness for Purple Day 3Health News:Surgical Groups Form 'Operation Patient Access: Quality Surgical Care for All' to Call Attention to Escalating Workforce Shortage 2Health News:Surgical Groups Form 'Operation Patient Access: Quality Surgical Care for All' to Call Attention to Escalating Workforce Shortage 3Health News:Surgical Groups Form 'Operation Patient Access: Quality Surgical Care for All' to Call Attention to Escalating Workforce Shortage 4Health News:Meningitis Angels to Support First Annual World Meningitis Day 2Health News:New data on cancer survival in Europe show more patients are cured 2Health News:New data on cancer survival in Europe show more patients are cured 3Health News:New data on cancer survival in Europe show more patients are cured 4Health News:New data on cancer survival in Europe show more patients are cured 5
... provides both pressure and flow calculations ... in a combined screen format utilizing ... Volcano's unique Doppler FloWire. Physiologic measurements ... to assess ambiguous or intermediate lesions, ...
... D-Series Plus from BERCHTOLD offers you a complete ... returning 98% of the bulb's original illumination to ... radiant energy., ,The light field is clear and ... and a neutral white color temperature of 4500 ...
... Convert any EMG/EP or EEG ... with these easy-to-install adapters. Available in ... Department at 1-800-245-3001 or 509-735-6481 for ... other manufacturers equipment. Sold individually. Adhesive ...
... elastic fabric, these head cap systems are ... begin testing. Each Electro-Cap System features pure ... 10-20 System. When you place your order, ... with your head cap system and whether ...
Medicine Products: